4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-031430
Chief Executive Officer sold 1,350 shares at $7.26 ($9,801)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-09-16 | Sale | −1,350 | $7.26 | $9,801 | 254,784 | D |
| Open-market sales · 1,350 sh · avg $7.26 · $9,801 | |||||||
Loading xslF345X03/doc4.xml…